A dual-action HIV antibody–drug conjugate forces Env to open, then blocks it, boosting virus neutralization up to tenfold in the lab.

An antibody test for the infectious disease mpox was successfully developed during the new clade 1b outbreak in Rwanda, the ...

A research team at Chalmers University of Technology, Sweden, has developed new laser technology that could lead to tiny, ...

Chronic hepatitis D coinfection affects an estimated 12 million people globally, with higher prevalence in low-income and middle-income countries, especially the African and Western Pacific regions.

An antibody test for the infectious disease Mpox was successfully developed during the new clade 1b outbreak in Rwanda, the first time that an assay of its kind has been validated within this setting.

Scientists fed Aedes aegypti mosquitoes blood laced with weakened rabies and Nipah viruses, then let those insects bite bats ...

March 18 (Reuters) - The U.S. Food and Drug Administration on Wednesday issued a draft guidance to help companies reduce ...

Creative Biolabs today announced the upgrade of its next-generation drug discovery pipeline with integrated AI-driven ...

Scientists at The University of Texas at Austin have pulled off their clearest look yet at the Andes hantavirus, mapping the virus’s surface entry complex at near-atomic detail. That intricate ...

JCV is a DNA polyomavirus and the primary aetiological agent of PML. Most adults carry JCV in its latent form, but the virus ...

Funding to accelerate internal pipeline and advance lead antibody programs toward in vivo efficacy studiesAI-driven, lab-in-the-loop platform designs, builds, and validates therapeutic-strength ...